Roberto Labianca

机构：University of Bergamo, Ospedale Papa Giovanni XXIII · ORCID：0000-0001-7149-822X

发表论文 545 篇 · 总被引 41259 次 · h-index 83

代表论文

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020 · Annals of Oncology · 被引 1404)
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials (2020 · The Lancet Oncology · 被引 308)
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer (2021 · Journal of Clinical Oncology · 被引 107)
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial (2022 · The Lancet Oncology · 被引 53)
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials (2022 · Journal of Clinical Oncology · 被引 51)
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer (2020 · JAMA Oncology · 被引 49)